NCR Atleos Corporation (NATL)

Marinus Pharmaceuticals Stock Forecast

Stock Price Forecast

The 4 analysts that cover Marinus Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $42.75, which forecasts a 15.20% increase in the stock price over the next year. The lowest target is $29 and the highest is $60.

Price Target: $42.75 (+15.20%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$29	$42.75	$45	$60
Change	-21.85%	+15.20%	+21.26%	+61.68%

Analyst Ratings

The average analyst rating for Marinus Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	1	1	1
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matt Bryson Wedbush	Wedbush	Buy Maintains $35 → $45	Buy	Maintains	$35 → $45	+21.26%	Aug 8, 2025
Shlomo Rosenbaum Stifel	Stifel	Hold Maintains $32 → $37	Hold	Maintains	$32 → $37	-0.30%	Aug 8, 2025
Matt Bryson Wedbush	Wedbush	Buy Initiates $35	Buy	Initiates	$35	-5.69%	Jun 20, 2025
Matt Summerville DA Davidson	DA Davidson	Strong Buy Maintains $60	Strong Buy	Maintains	$60	+61.68%	Mar 11, 2025
George Tong Goldman Sachs	Goldman Sachs	Hold Maintains $33 → $29	Hold	Maintains	$33 → $29	-21.85%	Mar 5, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

4.40B

Increased by 1.81%

from 4.32B

Revenue Next Year

4.59B

Increased by 4.46%

from 4.40B

EPS This Year

4.05

Increased by 229.44%

from 1.23

EPS Next Year

4.94

Increased by 21.80%

from 4.05

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	2.99B	3.55B	4.13B	4.19B	4.32B	4.40B	4.59B	4.84B
Revenue Growth	-	18.66%	16.40%	1.45%	3.01%	1.81%	4.46%	5.34%
EPS	-	2.63	1.53	-1.90	1.23	4.05	4.94	6.01
EPS Growth	-	-	-41.94%	-	-	229.44%	21.80%	21.78%
Forward PE	-	-	-	-	-	9.16	7.52	6.17
No. Analysts	-	-	-	-	-	8	7	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	4.6B	4.8B	5.2B
Avg	4.4B	4.6B	4.8B
Low	4.2B	4.4B	4.5B

Revenue Growth

Revenue Growth	2025	2026	2027
High	5.6%	10.0%	12.4%
Avg	1.8%	4.5%	5.3%
Low	-3.6%	-0.9%	-1.5%

EPS Forecast

EPS	2025	2026	2027
High	4.23	5.42	7.14
Avg	4.05	4.94	6.01
Low	3.82	4.31	4.90

EPS Growth

EPS Growth	2025	2026	2027
High	244.0%	33.7%	44.7%
Avg	229.4%	21.8%	21.8%
Low	211.0%	6.4%	-0.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.